Advertisement

Drugs

, Volume 58, Supplement 2, pp 346–348 | Cite as

The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

  • Clyde Thornsberry
  • P. Ogilvie
  • H. P. Holley
  • M. L. Hickey
  • M. E. Jones
  • I. A. Critchley
  • D. F. Sahm
Poster Presentations Extended Abstract

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klein JO. Selection of oral antimicrobial agents for otitis media and pharyngitis. Infect Dis Clin Prac 1995; 4 Suppl. 2: S88–94Google Scholar
  2. 2.
    Hansman D, Bullen MM. A resistant pneumococcus [letter]. Lancet 1967; II: 264–5CrossRefGoogle Scholar
  3. 3.
    Spika JS, Facklam RR, Plikaytic BD, et al. Antimicrobial resistance of Streptococcus pneumoniae in the United States. J Infect Dis 1991; 163: 1273–8PubMedCrossRefGoogle Scholar
  4. 4.
    Doem GV, Brueggemann A, Holley Jr HP, et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40: 1208–13Google Scholar
  5. 5.
    Thornsberry C, Brown SD, Yee YC, et al. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Infect Med 1993; 12 Suppl.: S15–24Google Scholar
  6. 6.
    Thornsberry C, Burton PH, Vanderhoof BH. Activity of penicillin and three third-generation cephalosporins against U.S. isolates of Streptococcus pneumoniae: a 1995 surveillance study. Diagn Microbiol Infect Dis 1996; 25: 89–95PubMedCrossRefGoogle Scholar
  7. 7.
    Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season. Diagn Microbiol Infect Dis 1997; 29: 249–57PubMedCrossRefGoogle Scholar
  8. 8.
    Baron EJ, Murray PR. Bacteriology. In: Murray PR, Baron EJ, Pfaller MA, et al., editors. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995: 246–662Google Scholar
  9. 9.
    National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard document M7-A4. Villanova, Pennsylvania, 1997Google Scholar
  10. 10.
    Bartlett JG, Breiman RF, Mandell LA, et al. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811–38PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Clyde Thornsberry
    • 1
  • P. Ogilvie
    • 1
    • 2
  • H. P. Holley
    • 3
  • M. L. Hickey
    • 4
  • M. E. Jones
    • 5
  • I. A. Critchley
    • 4
  • D. F. Sahm
    • 4
  1. 1.MRL Pharmaceutical ServicesBrentwoodUSA
  2. 2.Home Healthcare Labs of AmericaFranklinUSA
  3. 3.Glaxo Wellcome Inc.Research Triangle ParkUSA
  4. 4.MRL Pharmaceutical ServicesHerndonUSA
  5. 5.MRL Pharmaceutical ServicesUtrechtThe Netherlands

Personalised recommendations